Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr 1;24(suppl_1):S57-S74.
doi: 10.1093/jtm/tax026.

Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report

Affiliations
Review

Guidelines for the prevention and treatment of travelers' diarrhea: a graded expert panel report

Mark S Riddle et al. J Travel Med. .

Abstract

Background: : Travelers' diarrhea causes significant morbidity including some sequelae, lost travel time and opportunity cost to both travelers and countries receiving travelers. Effective prevention and treatment are needed to reduce these negative impacts.

Methods: : This critical appraisal of the literature and expert consensus guideline development effort asked several key questions related to antibiotic and non-antibiotic prophylaxis and treatment, utility of available diagnostics, impact of multi-drug resistant (MDR) colonization associated with travel and travelers' diarrhea, and how our understanding of the gastrointestinal microbiome should influence current practice and future research. Studies related to these key clinical areas were assessed for relevance and quality. Based on this critical appraisal, guidelines were developed and voted on using current standards for clinical guideline development methodology.

Results: : New definitions for severity of travelers' diarrhea were developed. A total of 20 graded recommendations on the topics of prophylaxis, diagnosis, therapy and follow-up were developed. In addition, three non-graded consensus-based statements were adopted.

Conclusions: : Prevention and treatment of travelers' diarrhea requires action at the provider, traveler and research community levels. Strong evidence supports the effectiveness of antimicrobial therapy in most cases of moderate to severe travelers' diarrhea, while either increasing intake of fluids only or loperamide or bismuth subsalicylate may suffice for most cases of mild diarrhea. Further studies are needed to address knowledge gaps regarding optimal therapies, the individual, community and global health risks of MDR acquisition, manipulation of the microbiome in prevention and treatment and the utility of laboratory testing in returning travelers with persistent diarrhea.

Keywords: Clinical practice guideline; emporiatrics; evidence-based medicine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Travelers’ diarrhea management algorithm Footnote: *All Dysentery is considered severe

Comment in

References

    1. Steffen R, Hill DR, DuPont HL.. Traveler's diarrhea: a clinical review. JAMA 2015; 313:71–80. - PubMed
    1. Murray CJ, Barber RM, Foreman KJ. et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet 2015; 386:2145–91. - PMC - PubMed
    1. Travelers' diarrhea. National Institutes of Health Consensus Development Conference Statement. Natl Inst Health Consens Dev Conf Consens Statement 1985; 5:1–7. - PubMed
    1. Riddle MS, Arnold S, Tribble DR.. Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis. Clin Infect Dis 2008; 47:1007–14. - PubMed
    1. Zaidi D, Wine E.. An update on travelers' diarrhea. Curr Opin Gastroenterol 2015; 31:7–13. - PubMed

Substances